| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.07M | 18.39M | 16.27M | 27.45M | 22.05M | 17.98M |
| Gross Profit | 9.65M | 13.76M | 8.17M | 16.41M | 13.26M | 11.21M |
| EBITDA | 3.88M | 5.74M | 4.22M | 11.29M | 8.61M | 6.15M |
| Net Income | 623.00K | 337.00K | 40.00K | 5.91M | 4.54M | 3.45M |
Balance Sheet | ||||||
| Total Assets | 35.96M | 38.48M | 37.00M | 38.75M | 31.14M | 24.28M |
| Cash, Cash Equivalents and Short-Term Investments | 10.30M | 10.91M | 11.87M | 19.10M | 15.36M | 12.67M |
| Total Debt | 1.08M | 1.22M | 415.00K | 691.00K | 857.00K | 566.00K |
| Total Liabilities | 9.34M | 11.04M | 9.66M | 11.39M | 9.32M | 7.12M |
| Stockholders Equity | 26.63M | 27.44M | 27.34M | 27.36M | 21.83M | 17.16M |
Cash Flow | ||||||
| Free Cash Flow | 7.56M | -309.00K | -6.49M | 6.57M | 3.14M | 5.71M |
| Operating Cash Flow | 7.65M | 4.58M | -784.00K | 11.27M | 7.35M | 9.05M |
| Investing Cash Flow | -5.12M | -4.57M | -3.84M | -6.98M | -5.71M | -3.34M |
| Financing Cash Flow | -963.00K | -967.00K | -1.09M | -563.00K | -448.00K | 3.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £48.27M | 10.81 | 17.36% | 4.20% | 5.46% | 12.34% | |
75 Outperform | £450.88M | 27.44 | 26.93% | ― | 121.45% | 345.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | £41.80M | -17.38 | 2.30% | 2.02% | 20.83% | ― | |
55 Neutral | £51.01M | -18.64 | -9.80% | ― | -28.03% | -1213.04% | |
52 Neutral | £34.88M | 5.88 | 2.29% | 3.67% | -21.33% | -11.35% | |
45 Neutral | £714.70K | -0.16 | -197.13% | ― | -54.10% | 85.53% |